Megan brings over 15 years of industry experience, most recently at Mirati Therapeutics, where she was Head of Corporate Communications, responsible for external and internal communications, including for the company’s first FDA approved product, executive thought leadership and crisis communications. Previously, Megan held senior leadership roles at biotech- and pharma-focused strategic communications and public affairs agencies, counseling clients on FDA approvals, launches and stakeholder relations. Megan is a graduate of the University of Pittsburgh, and holds a Masters degree from the S.I. Newhouse School and the Maxwell School of Citizenship and Public Affairs at Syracuse University.